or
forgot password

Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects


N/A
18 Years
N/A
Open (Enrolling)
Both
Healthy

Thank you

Trial Information

Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects


RLIP76 is shown to be over expressed in a variety of cancer cells. However, no study has yet
been done on its expression on normal cells. The studies proposed in this project will study
the expression of RLIP76 in blood cells of healthy human subjects in the population of North
Texas region.


Inclusion Criteria:



- Healthy as defined by lack of serious health conditions or diseases

Exclusion Criteria:

- Children, pregnant women, prisoners, persons with any medical condition that
precludes phlebotomy and persons unwilling or unable to provide consent will be
excluded.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

Expression of RLIP76 in red blood cells and white blood cells of 100 healthy human subjects.

Outcome Time Frame:

3 years

Safety Issue:

No

Principal Investigator

Sanjay Awasthi, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of North Texas Health Science Center

Authority:

United States: Institutional Review Board

Study ID:

2008-32

NCT ID:

NCT00762801

Start Date:

September 2008

Completion Date:

September 2011

Related Keywords:

  • Healthy
  • RLIP76
  • RLIP76 plays a role in every stage of cancer, right from evasion of apoptosis and signaling to an uncontrolled growth

Name

Location
University of North Texas Health Science Center Fort Worth, Texas  76109